Navigation Links
Drug combinations key in treating neurodegenerative diseases
Date:1/30/2009

AUGUSTA, Ga. Combining the benefits of multiple drugs in a single pill may hold the key to treating neurodegenerative diseases, Medical College of Georgia researchers say.

Drugs that protect neurons, for example, can be used with those targeting memory to make real progress in treating diseases such as Alzheimer's, says Dr. Jerry Buccafusco, founding director of the MCG Alzheimer's Research Center.

"We realize that with neurodegenerative diseases there will not be one magic bullet," Dr. Buccafusco says. "Developing new therapeutics will require an attack on many different levels. But, right now, there are no FDA-approved compounds out there that are significantly disease-modifying. We're at the point where we're just getting to that."

His review of trends in pharmacological research of neurodegenerative diseases is the featured article in the January issue of NeuroTherapeutics, the journal of the American Society for Experimental NeuroTherapeutics.

Alzheimer's treatment, for instance, should combine molecules that protect neurons from plaque buildup with approved therapies like cholinesterase inhibitors, which treat cognition and memory loss, Dr. Buccafusco says.

Dr. Buccafusco also cited several novel drug candidates developed at the MCG Alzheimer's Research Center, including two molecules prevent cell death in the brain and improve cognition, reaction time and attention.

"What we have to do now is look at drugs that have already been developed to address very specific disease targets and come up with new ways to combine constituent groups of active molecules into a single therapeutic agent," Dr. Buccafusco says. "Drugs should target more than one particular molecular structure and molecular receptor in the central nervous system. The technology is available to design molecules that have multiple properties all in one package. This approach could represent a new frontier for pharmacology."

Advantages to multi-functional drug compounds, he says, include fewer side effects.


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia
Source:Eurekalert  

Related medicine news :

1. Scientists call up stem cell troops to repair the body using new drug combinations
2. Drug Combinations Putting Seniors at Risk
3. Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
4. Do bacterial combinations result in enhanced cytokine production? No!
5. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
6. Breast cancer drug shows promise for treating, preventing progestin-dependent tumors
7. Photos: Apples iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute
8. Older Drug Effective in Treating Pediatric Nerve Cancer
9. ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrigs Disease
10. Treating gum disease linked to lower medical costs for patients with diabetes
11. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug combinations key in treating neurodegenerative diseases
(Date:5/2/2016)... ... May 02, 2016 , ... ... event, will be held at the Bellagio Hotel in Las Vegas, NV from ... Work (NASW) will be co-hosting the event. , This year’s conference will offer ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... recently completed two groundbreaking studies that determined that the adjustability and adaptability of ... in the prevention of pressure injuries, which are now referred to as “pressure ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised that ... on the list of “ 5 US Cities with the Highest Plastic Rates .” ... Miami. The results were calculated using a survey by RealSelf and combining ...
(Date:5/2/2016)... ... 02, 2016 , ... MedaCheck, a leading medication and disease ... announced its partnership with GrandView Health Services. , With decades of experience, Grandview ... prescription drug pharmacy services to thousands of residents. Serving Indiana, Ohio, Michigan, Tennessee ...
(Date:5/2/2016)... ... , ... The Evolve Paddle Board Company- which specializes in the production and ... their partnership with Yoloha Yoga- producers of high quality cork yoga mats. Together they ... seen a dramatic rise in popularity throughout the last few years. The makers of ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
Breaking Medicine Technology: